4537 |
Maximal Luminal Gain with Directional or Rotational Atherectomy Followed by DCB May the Optimal Strategy |
Ravish Sachar |
Apr. 28. 18 |
4536 |
Role of FFR in ACS (uAP, NSTEMI, and STEMI): Still Doubtful? |
Bon-Kwon Koo |
Apr. 28. 18 |
4535 |
Drug-Technology for BTK Intervention: Barriers and Perspectives |
Lawrence A. Garcia |
Apr. 28. 18 |
4534 |
All the Data from IRIS-FFR Registry |
Seung-Jung Park |
Apr. 28. 18 |
4533 |
Clinical Implication of Anatomical Variation of Below the Knee Arteries |
Yoshiaki Yokoi |
Apr. 28. 18 |
4532 |
Updated Outcome of Real-World Bifurcation Registry: COBIS Series |
Hyeon-Cheol Gwon |
Apr. 28. 18 |
4531 |
Contemporary Thinking of Optimal Bifurcation PCI: Current State-of-the-Art |
Yves R. Louvard |
Apr. 28. 18 |
4530 |
Endovascular Therapy Versus Surgical Reconstruction in CLI: First Option Controversy |
Osamu Iida |
Apr. 28. 18 |
4529 |
PCI vs. CABG in LM and MVD: Time to Apply FFR for Decision-Making: Updated Data and FAME-3 |
William F. Fearon |
Apr. 28. 18 |
4528 |
Excel and Noble Trials: What Is the Impact on Clinical Practice Two Years Later? |
Imad Sheiban |
Apr. 28. 18 |